- 4-Week # shares sold: 118
- 12-Week # shares sold: 118
- 24-Week # shares sold: 5,118
Other U.S. multinationals could also face hefty back-tax bills.
It took 12 months for Teva to gain FTC approval to buy Allergan's U.S. generics business. Future mergers could face the same long scrutiny.
The deal could be worth $1.5 billion.